The ELISA human monokine test induced by interferon gamma (CXCL9) (Hu MIG) is used to quantify the Hu MIG protein in human serum, cell culture supernatants or other body fluids.The assay will recognize the potential for human...
The human monokine-induced ELISA assay of interferon gamma (CXCL9) (Hu MIG) is used to quantify the Hu MIG protein in human serum, The assay will only recognize the human natural and recombinant MIG.Method principle The ELISA (immuno-enzymatic test) solid phase sandwich for human MIG is designed to measure the amount of the target bound between a pair of matched antibodies.A target specific antibody was pre-released in the bloodstream. The sandwich is formed by binding the second antibody (detector) to the target on a different epitope from the capture antibody.A conjugated antibody to the enzyme binds the formed sandwich.After incubation and washing steps to remove the microplate A substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal.The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample.Strict validation Each batch manufactured from this ELISA kit is tested for quality for criteria such as sensitivity, the specificity, accuracy and consistency of batch to batch.See the product manual for more information on validation.
MIG (monokine induced by interferon gamma), or CXCL9, belongs to the subfamily of chemokines CXC. The main function of this soluble protein is the recruitment of leukocytes at infection and inflammation sites. MIG binds to a receptor that is selectively expressed in activated T-cells and is therefore a critical mediator of T-cell migration in T-cell dependent immune responses. This shows antiviral activity. Like IP-10, it binds to the CXCR3 chemokine receptor in the immune responses of Th1 and has inhibitory functions in neovascularization, is an inhibitor for hematopoietic stem cells and shows anti-tumour effects. In addition, there is evidence that MIG plays an important role in mediating cell recruitment and activation necessary for inflammation and repair of tissue damage, for example in liver diseases.
Sensitivity
Sensitivity of the dosage: 4.0 pg/ml.
Measurement range
Dose range: 31.3-2.000 pg/ml.
Duration of dosing
Total duration of dosing: 3 h 10 min.
Reproducibility
Coefficient of variation in intra-dose 5.4%, inter-dose 11%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15541887 |
| Specifications |
| Accession number | Q07325 |
| Dose range | 31.3-2.000 pg/ml |
| Sensitivity of the dosage | 4.0 pg/ml |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Type of sample | Serum, Surnatant |
| Target species | Human |
| For use with (application) | ELISA |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 4283 |
| Gene symbol(s) | CMK,Humig,MIG,SCYB9,crg-10 |
| Coefficient of inter-dose variation | 11% |
| Coefficient of intra-dose variation | 5.4% |
| Contents of kits | 10x lysis pad, Adhesive plate covers, Biotinylated detection anticorps, Biotinylated detection anticorps, lyophilized, 96-well pre-coated microplate, 96-well pre-coated microplate, Sample diluent, Wash buffer concentrate, Wash buffer concentrate, Solution d |
| Marker or dye | HRP |
| Quantity | 128 Tests |
| Regulatory status | RUO |
| Synonym | CRG-10, Humig, SCYB9, CXCL9 |
| Target | Human |
| Test time | 20 min |
| Physical characteristics |
| Volume of sample | Serum, 50 μl; supernatant, 50 μl |
| Storage and shipping |
| Storage conditions | -20°C |
| Total duration of dosing | 3 h 10 min |
Origin and customs
| Manufacturer ref. | BMS285INST |
|---|
| Country of origin | Autriche |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.